Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-05 · accession 0001765581-25-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-07 | 2025-03-07 | JAZZ | Iannone Robert | EVP, CMO, Gbl Head of R, D | S - Sale | $138.60 | -7,080 | 82.0K | -8% | -$981.3K |
| 2025-03-07 | 2025-03-05 | JAZZ | Iannone Robert | EVP, CMO, Gbl Head of R, D | D - Sale to Iss | $138.95 | -5,239 | 89.1K | -6% | -$728.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-07 | S | D | 5,532 | $138.21 | 83,572 | D | — | — | (F3) Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $138.19 to $138.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2025-03-07 | S | D | 1,548 | $140.00 | 82,024 | D | — | — | |
| 3 | Common | Ordinary Shares | 2025-03-05 | D | D | 5,239 | $138.95 | 89,104 | D | — | — |